E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/27/2016 in the Prospect News PIPE Daily.

RegeneRx negotiates $1.75 million private placement of common shares

Maxim sells 5,147,059 shares at $0.34 per share with warrant coverage

By Devika Patel

Knoxville, Tenn., June 27 – RegeneRx Biopharmaceuticals, Inc. said it plans a $1.75 million private placement of stock. Maxim Group LLC is the agent.

The company will sell 5,147,059 common shares at $0.34 apiece. The price per share represents a 33.33% discount to $0.51, the closing share price on June 24.

The investor will also receive warrants for 5,147,059 shares, which are each exercisable at $0.51 for 66 months. The strike price is identical to the June 24 closing price.

Settlement is expected June 30.

The biopharmaceuticals developer is based in Rockville, Md.

Issuer:RegeneRx Biopharmaceuticals, Inc.
Issue:Common shares
Amount:$1.75 million
Shares:5,147,059
Price:$0.34
Warrants:For 5,147,059 shares
Warrant expiration:66 months
Warrant strike price:$0.51
Agent:Maxim Group LLC
Pricing date:June 27
Settlement date:June 30
Stock symbol:OTCBB: RGRX
Stock price:$0.51 at close June 24
Market capitalization:$49.42 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.